While most casino apps in Australia are reliable, some clearly aren’t. Before you start using an Australian real money casino app, a few small optimisations can make your sessions smoother. The best casino apps in Australia complete this process quickly, often within hours of your documents being submitted. Make sure you turn push notifications on because this is how you’ll find out about mobile-focused offers. Mobile casinos in Australia offer the same bonuses you’d find on desktop, from welcome packages and free spins to cashback, plus mobile-exclusive promos on top. We also confirm each platform uses SSL encryption to protect your data and payments, and we look for responsible gambling tools such as deposit limits, session reminders, and self-exclusion options. Casino apps that clearly explain deposit limits, support mobile-friendly payment options, and offer straightforward withdrawal processes score higher in our rankings. Beyond raw performance, we assess how the app feels during an actual session.

Not crazy in the overall scheme of phone usage, but be aware that live gaming uses more data than pokies and table games. Over 87% of Australians use their phones to gamble online, compared to under 58% who use a computer, smart TV, or tablet. Let’s take a closer look at what you can expect with these game types on your phone or tablet. During testing, we check whether pokies, table games, and live dealer titles are fully available on mobile and whether they load quickly without interface issues. We focus on factors that matter most to you, including performance, gameplay, game variety, payments, and security. Our team tests every casino app on this page using real mobile devices to evaluate how smoothly the platform performs during actual play. Whether you’re on iPhone or Android, you don’t need to download anything or give up storage space. These operators offer secure mobile websites, fair games, and quick payments.

We still refer to these casinos as “apps” because they offer a very similar experience. Casino apps in Australia usually come in the form of mobile casinos. With over two decades of experience in iGaming, he combines sharp analysis with a player-first perspective. Rob launched Casino Beacon to help demystify the online casino world. Learn how Aussie pokies work, understand RTP and features, and discover the best Australian-friendly casinos for online pokie play.

Compare Australian-friendly payment methods, avoid unnecessary fees, and understand how AUD banking works at online casinos. Mobile data or a trusted private network is usually the safer choice for real-money casino play. Look for clear support, strong security, practical payment methods, and transparent terms on bonuses and withdrawals. Avoid public Wi-Fi for deposits or withdrawals and keep your device updated. Most games use the same core features and payouts as desktop versions, although the interface is optimized for smaller screens. Strong choices include Lucky Elf, Fair Go, Winz, Ozwin, Ripper Casino, and other sites that combine smooth mobile play with practical payouts and useful promotions. Mobile casinos are convenient, but a few simple habits can make your sessions smoother and more secure.

Live Casino

Fortunately, the best casino apps promote responsible gambling measures, offer tips for staying safe, and provide contact information for helpful organisations. Most mobile casinos in Australia offer browser-based play rather than apps. Mobile casinos usually provide full cashier access, including deposits, withdrawals, and verification, although payout speed still depends on the casino and method used. Many Aussie-friendly casinos are fully mobile compatible and let players access real money games directly through mobile browsers, with some also offering app-style options. Modern mobile casino websites work well in most phone browsers, but it's still worth understanding when an app or shortcut might offer an advantage. In our experience, the best mobile casinos are the ones you barely notice. Ripper brings together games from providers including Betsoft, BGaming, and Pragmatic Play, giving mobile players plenty of choice across pokies, table games, and live casino titles.

Most Australia-friendly casinos use the same bonuses on desktop and mobile, but the experience of claiming them can vary. A casino is not genuinely mobile-friendly just because its homepage opens on a phone. Combined with regular promotions and a straightforward mobile site, it's a good choice if you prefer trying a casino before committing your own money. Instant cashouts are another plus for players who value quick access to their winnings. They make it easy to deposit, play, contact support, and withdraw your winnings without struggling with awkward menus or cramped layouts. We compare these Australia-friendly sites by mobile performance, game variety, bonus value, and the type of player each casino suits best.

This sign-up offer is valid for players registered at CoinCasino after December 2024 and for the first deposit only.

📊 Performance Testing Results (december

Before choosing a bonus, check that it is easy to activate, simple to track on your phone, and suitable for the games you actually want to play. Pages load quickly, the cashier is simple to use, games run smoothly, and withdrawals are straightforward. Regular promotions and a no deposit offer make it a good all-round option if you enjoy trying different games from your phone. Ozwin gives new players a chance to explore its mobile casino with a $20 free sign-up offer before making a deposit. Fair Go is a good choice if you prefer playing through your mobile browser instead of downloading an app. For many players, the best mobile casino is simply the one that feels smooth, stable, and easy to use when they are actually trying to deposit, play, and withdraw. Mobile casinos let Australian players access pokies, table games, live dealer tables, and cashier tools straight from their phones or tablets.

Iphone Vs Android Casino Apps

Since online casinos can’t hold an Australian licence, casino apps don’t make it onto either store. In this guide, we compare the best mobile casinos down under, all tested firsthand, and explain how to access them securely despite Australia’s local restrictions. Add biometric logins, easy navigation, and push notifications, and playing on your phone beats the desktop experience. Get exclusive updates, offers, and more delivered to your inbox. For most players, browser play is easiest because it avoids downloads and keeps access simple.

Most Australia-friendly mobile casinos work directly in your phone or tablet browser, although some also offer app or shortcut-style options. These are the questions we hear most often from Australian players about mobile casinos, casino apps, browser play, security, and mobile withdrawals. The best online casino apps in Australia partner with trusted software providers that provide return to player (RTP) figures and other important game stats. Android gives you a wider choice of devices and occasional access to optional casino APKs outside the Play Store, while iPhone offers consistently smooth performance and quick updates. The real test is whether games load reliably, the cashier remains easy to use, support is accessible, and withdrawals can be managed without fighting a cramped interface. Its SpinLogic-powered pokie collection, regular free spin offers, and simple browser access make it easy to play on both Android and iPhone without installing extra software. The best Australia-friendly mobile casinos do more than simply load on a phone.

A great mobile casino is about lmct+ casino login much more than fitting onto a smaller screen. The random number generator doesn't change based on device. Mobile devices now account for 60-70% of all online casino traffic in regulated markets. Mobile gaming now accounts for 60-70% of all online casino traffic in regulated markets CasinoBeats is your trusted guide to the online and land-based casino world. Our editorial team operates separately from commercial interests, ensuring that reviews, news, and recommendations are based solely on merit and reader value.

The right features can make mobile gaming faster, easier, and more enjoyable, letting you focus on the fun instead of struggling with slow load times and cluttered menus. It prohibits companies from offering online casino games to Australians, but it imposes no penalties on individuals who choose to play. You’ll also get the same account across all your devices, so you can start a session on your phone and pick it up on your desktop. The good news is that many established, internationally licensed mobile casinos for real money still accept Australian players. It also leads the App Store and Google Play Store to block casino apps targeting AU users. This setup exists because the Interactive Gambling Act 2001 (IGA) prohibits online casinos from offering their services to players in Australia.

Real money casino apps in Australia deliver fun and excitement, but it’s easy to get carried away. The best casino apps in Australia invest in their platform and make it easy to get help. The best casino apps in Australia typically handle withdrawals within a single business day, although 1-3 days is still the standard across the industry. The average AU online casino app will require you to go through a Know Your Customer (KYC) process before approving withdrawals. Besides offering convenience and smooth gameplay, mobile casinos in Australia also deliver special promos you won’t see through desktop play. A casino app should give you access to a large portion of the platform’s game library without sacrificing performance. Here are some key features that separate the best casino apps from the rest.

Most casinos offer demo/fun mode on mobile, but availability varies by jurisdiction and game provider. He loves getting into the nitty gritty of how casinos and sportsbooks really operate in order to make solid recommendations based on real experiences. The Australian mobile gaming market features plenty of helpful tools that help you keep sessions fun instead of frantic. Legit casino apps display their licence number and regulator (such as Curaçao or Anjouan) at the bottom of every page, often with a clickable seal that links to the regulator’s verification page. I don’t recognise these game providers, and there’s no RTP info. A poorly maintained online casino app is a warning sign in itself, and it usually comes bundled with other problems like buried bonus terms and unreachable support.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.

In October 2022, the company agreed to buy British diagnostics firm, The Binding Site Group, in an all-cash deal for US$2.6 billion from Nordic Capital. In April 2021, Thermo Fisher Scientific announced the acquisition of PPD, Inc., a contract research organization, for a total cash purchase price of $17.4 billion-plus the assumption of approximately $3.5 billion of net debt. On August 13, the company announced that its offer to acquire all of the ordinary share had lapsed, and it terminated the acquisition agreement. In August, the company acquired Patheon, a contract development and manufacturing organization serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. In March, the company announced it would acquire Core Informatics, provider of cloud-based platforms supporting scientific data management. On May 27, 2016, the company announced it would acquire FEI Company for $4.2 billion, a manufacturer of electron microscopes. In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. In May 2011, Thermo Fisher Scientific Inc. bought Phadia to expand into the testing of allergies and autoimmune diseases for €2.47 billion ($3.5 billion) in cash.

It made broad patents covering Enhanced GFP (EGFP), GFP-based biosensors and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. In 1990, Thermo Fisher Scientific (then known as Thermo Instrument Systems) acquired mass spectrometer manufacturer Finnigan Instrument Corporation. In April 2007, Genevac was sold to Riverlake Partners LLC and the merger closed with FTC approval. However, the Federal Trade Commission ruled that this acquisition was anti-competitive regarding centrifugal evaporators, requiring Fisher to divest Genevac. It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, Adrians Casino and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The merger closed on November 9, 2006, and the merged company is now called Thermo Fisher Scientific.

This acquisition is anticipated to close in early 2017 and will contribute to the growth of Thermo's Analytical Instruments business group. In January 2016, the company announced it would acquire Affymetrix for $1.3 billion. The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. Life Technologies was originally formed in 2008 through a $6.7B merger of Invitrogen, a cell therapy, and Applied Biosystems. In April 2013, after a competitive bidding with Hoffmann-La Roche, Thermo Fisher acquired Life Technologies Corporation for US$13.6 billion in a deal, adding further service lines related to advanced DNA sequencing and genetic testing. In December 2010, Thermo Fisher Scientific announced its acquisition of Dionex for $2.1 billion.

In March 2019, Thermo Fisher Scientific announced its entry into the gene therapy manufacturing market with a $1.7 billion cash acquisition for Brammer Bio. Thermo Scientific products address a range of needs from sample, material characterization, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. As the world’s leader in serving science, our professionals develop critical solutions—and build rewarding careers. Discover the resources that match your professional development interests, a culture that welcomes your ideas, and opportunities that only a global leader can provide. Over 50 million tons of her cells have been produced and used in over 60,000 scientific studies touching virtually every realm of medicine, including the development of polio vaccines, gene mapping, in-vitro fertilization, and multitudes more. In 2021, Thermo Fisher announced the construction of a cell therapy development, manufacturing and collaboration center in cooperation with University of California, San Francisco on the school's Mission Bay campus.

Grab Deals Before They're Gone

In June 2020, Thermo Fisher Scientific was reported to sell its equipment to security services in China for use in what was alleged as part of a genetic surveillance program. In February 2019, Thermo Fisher Scientific announced that it would stop selling its equipment in Xinjiang. In May 2023, Thermo Fisher partnered with Pfizer, with plans to work together on expanding testing capabilities for lung and breast cancer patients. The collaboration was designed to scale up the manufacturing of Moderna’s COVID-19 vaccine and other investigational mRNA products. Previously, he worked for clinical diagnostics provider Dade Behring Inc., serving as President–Americas. After the merger creating Thermo Fisher Scientific in 2006, he was named Executive Vice President and President of its Analytical Technologies business, and in 2008 he became the company’s Chief Operating Officer. In July 2025, Thermo Fisher added drug manufacturing capabilities in the United States through its purchase of a sterile fill-finish and packaging plant from Sanofi in Ridgefield, New Jersey.

In February 2025, Thermo Fisher announced the acquisition of Solventum’s purification and filtration business for $4.1 billion. In July 2023, the business announced it would acquire CorEvitas, LLC from Audax Private Equity for more than $900 million in cash. In January 2022, Thermo Fisher Scientific acquired PeproTech, a developer and manufacturer of recombinant proteins, for $1.85 billion. In November, the business announced it would acquire PharmaFluidics and its μPAC range of micro-chip-based chromatography products. In March 2020, Thermo Fisher Scientific agreed to purchase Qiagen, a molecular diagnostics company, for $10.1 billion. In November the company announced it would acquire MTI-GlobalStem, a previously privately held company that develops reagents for cell transfection, neurobiology and stem cell research.

Green Solutions

In the 1990s, Fisher, with partner Intertech Corporation of Atkinson, New Hampshire, set up a pharmaceutical testing and certification lab in Moscow, Russia, to serve with the Russian Federation's Ministry of Health and Medical Industry needs. The public entity was called Fisher Scientific International Inc., and based in Hampton, New Hampshire. Fisher was acquired by Morristown, New Jersey–based Allied Corporation in 1981 for $330 million. In 1968, it purchased Massachusetts-based Jarrell-Ash Company, a producer of optical instrumentation, particularly for emission and atomic absorption spectroscopy. It acquired Pfeiffer Glass, Inc. in 1966, a manufacturer of high accuracy volumetric pipettes. In 1959 the company opened an instrument and supplies facility in Indiana, Pennsylvania. In 1957, the company purchased the New York–based medical apparatus supply company E. In 1955, Fisher established a chemical manufacturing facility in Fair Lawn, New Jersey.

The merger was complete in November 2006, and technology transfer to a US site was completed during 2007 and 2008. It focused on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety, and education. It acquired Chicago-based Stansi Scientific Company in 1967, expanding into educational science supplies. As part of our global team, what you do contribues directly to our Mission, to enable our customers to make the world healthier, cleaner and safer. The images were claimed to validate the effectiveness of antibody products which have uses including Western blots. In 2013, Opengate Capital Group LLC filed suit against Thermo Fisher Scientific for selling it a manufacturing plant controlled by the Gulf Cartel. In June 2021, The New York Times reported that, despite bans, Thermo Fisher Scientific equipment continued to be sold to police in Xinjiang.